A cerebrospinal fluid glucose biosensor for diabetes mellitus

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Neuroscience

Background:

• Accurate cerebrospinal fluid (CSF) glucose monitoring is crucial for diagnosing neurological conditions.
• Current methods for CSF glucose analysis can be invasive or time-consuming.
• Developing rapid, real-time CSF glucose measurement tools is a significant clinical need.

Purpose of the Study:

• To introduce and evaluate a novel polarimetric biosensor for measuring glucose concentration in cerebrospinal fluid (CSF).
• To assess the in vitro performance and in vivo accuracy of the CSF glucose biosensor.
• To determine the correlation between the biosensor's readings and standard laboratory CSF glucose assays.

Main Methods:

• Development of a polarimetric biosensor designed to measure the optical rotation of plane polarized light.
• In vitro testing of the biosensor using glucose solutions across a concentration range of 0-400 mg/dl.
• In vivo studies involving anesthetized adult dogs subjected to intravenous glucose loading, with simultaneous CSF polarimeter readings and laboratory CSF glucose assays.

Main Results:

• The biosensor demonstrated a linear response and good sensitivity in vitro.
• A high correlation (r = 0.98) was observed between in vivo CSF polarimeter readings and laboratory CSF glucose measurements.
• The study noted a rapid sensor response (1-30 min) post-glucose loading, with a lag time (45-60 min) before peak CSF readings compared to peak blood glucose.

Conclusions:

• The polarimetric CSF glucose biosensor shows significant potential for accurate and real-time glucose monitoring in cerebrospinal fluid.
• In vivo results suggest that optical rotation changes due to glucose are the primary contributors to the biosensor's signal in CSF.
• This technology extends the application of optical rotation measurements to CSF analysis, offering a promising new diagnostic approach.